Trevi Therapeutics
TRVI
TRVI
153 hedge funds and large institutions have $627M invested in Trevi Therapeutics in 2025 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 65 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
+16
Holders Change %
+11.68%
% of All Funds
2.05%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.09%
New
39
Increased
65
Reduced
31
Closed
23
Calls
$7.77M
Puts
$3.73M
Net Calls
+$4.05M
Net Calls Change
-$4.46M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$23.3M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$21.8M |
| 3 |
BlackRock
New York
|
+$15.8M |
| 4 |
O
OrbiMed
New York
|
+$12M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$10.9M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$18.8M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$9.22M |
| 3 |
ABG
Ally Bridge Group
New York
|
-$4.32M |
| 4 |
VA
VR Adviser
New York
|
-$3.87M |
| 5 |
Millennium Management
New York
|
-$3.64M |
